The Global Health Body Raises Alert Over Critical Scarcity of Weight-Loss Injections

Under one in 10 people eligible to benefit from weight-loss injections such as Wegovy have access to them, states the global health agency as it publishes its inaugural advice on the medications.

Given more than one billion individuals worldwide now obese, it is urging more widespread and fairer availability to this class of drugs.

Per projections, over two billion could be living with obesity by 2030 if no action is taken.

"The new guidelines affirms that obesity is a chronic disease that can be managed with holistic and continuous treatment," remarked its chief Tedros Adhanom Ghebreyesus.

Significant expense, insufficient output, and distribution challenges are significant hurdles to broad availability to the treatments that can assist patients in reducing substantial body mass, explains the organization.

Skinny Jab Scarcity

Even under the present best projected scenario, the manufacturing of GLP-1 therapies would only suffice for about 100 million people – less than 10% of the global need, as stated by the WHO.

The recommendation encourages nations and manufacturers to widen availability, through approaches including voluntary licensing.

The intellectual property rights on the active ingredient – the main ingredient of a leading brand – is due to expire in multiple nations in 2026.

The Way Obesity Jabs Work

The injections replicate a body's own hormone to delay gastric emptying, curb appetite and increase satiety so users eat less.

Individuals usually see weight reduction after several weeks of starting on the weekly injections.

Studies indicates patients may put most of the weight back on after a year of stopping the medication, as their typical appetite resume.

To be carrying excess weight elevates your risk for contracting medical conditions, like type 2 diabetes, cardiovascular issues, stroke, and certain malignancies.

Obesity impacts people in every country and was linked to millions of deaths worldwide in 2024, per the health agency.

Shawn Carter
Shawn Carter

Maya Chen is a passionate gaming journalist with over a decade of experience covering esports and indie game developments.